| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.007 |